Loading clinical trials...
Loading clinical trials...
B-acute lymphoblastic leukaemia (ALL) is the most common childhood malignancy. Despite enhancement of childhood B-ALL outcome, relapses remain difficult to treat. Several studies in adult acute myeloi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Angers
NCT07284433 · Lymphoma Diffuse Large B-cell, Leukemia and Lymphoma, and more
NCT05453500 · B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
NCT05157971 · B Acute Lymphoblastic Leukemia, Ph-Like Acute Lymphoblastic Leukemia
NCT07224100 · B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Lymphoblastic Leukemia/Lymphoma With t(9;22)(q34.1;q11.2); BCR-ABL1, and more
NCT07106749 · Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia/Lymphoma
University Hospital of Amiens
Amiens
University Hospital of Angers
Angers
University Hospital of Besancon
Besançon
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions